ProShare Advisors LLC Purchases 15,841 Shares of Astera Labs, Inc. $ALAB

ProShare Advisors LLC increased its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 9.4% in the third quarter, Holdings Channel reports. The fund owned 184,326 shares of the company’s stock after purchasing an additional 15,841 shares during the quarter. ProShare Advisors LLC’s holdings in Astera Labs were worth $65,615,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in ALAB. Greenleaf Trust increased its position in Astera Labs by 1.8% during the 2nd quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock valued at $966,000 after purchasing an additional 36 shares during the period. Parkside Financial Bank & Trust raised its holdings in shares of Astera Labs by 74.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock valued at $46,000 after purchasing an additional 41 shares in the last quarter. Integrated Advisors Network LLC raised its holdings in shares of Astera Labs by 4.8% in the 3rd quarter. Integrated Advisors Network LLC now owns 983 shares of the company’s stock valued at $350,000 after purchasing an additional 45 shares in the last quarter. Interchange Capital Partners LLC lifted its position in shares of Astera Labs by 4.4% in the 3rd quarter. Interchange Capital Partners LLC now owns 1,187 shares of the company’s stock worth $423,000 after purchasing an additional 50 shares during the period. Finally, Glenmede Trust Co. NA lifted its position in shares of Astera Labs by 2.7% in the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after purchasing an additional 51 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on ALAB shares. Jefferies Financial Group increased their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Zacks Research downgraded shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Weiss Ratings lowered Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a report on Friday, October 23rd. Susquehanna increased their target price on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. Finally, Barclays increased their target price on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Eleven analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $340.79.

Astera Labs Stock Performance

Shares of ALAB stock opened at $258.70 on Monday. The business’s fifty day simple moving average is $308.12 and its 200-day simple moving average is $254.98. The company has a market cap of $44.88 billion, a PE ratio of 128.07 and a beta of 3.68. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The business’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts forecast that Astera Labs, Inc. will post 2.71 earnings per share for the current year.

Insider Activity at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the sale, the director owned 253,863 shares of the company’s stock, valued at approximately $71,114,642.19. This trade represents a 41.89% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the sale, the chief operating officer owned 1,119,038 shares in the company, valued at $380,864,583.30. The trade was a 7.49% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 408,558 shares of company stock worth $127,306,034 over the last ninety days. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.